| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 6.152 | 5.789 | 6.172 | 8.540 | 7.343 | 2.212 | 553 |
| Total Income - EUR | - | - | 0 | 6.152 | 5.789 | 6.172 | 8.540 | 9.305 | 2.212 | 553 |
| Total Expenses - EUR | - | - | 0 | 485 | 1.788 | 669 | 1.026 | 3.244 | 3.031 | 5.900 |
| Gross Profit/Loss - EUR | - | - | 0 | 5.668 | 4.001 | 5.503 | 7.514 | 6.061 | -818 | -5.348 |
| Net Profit/Loss - EUR | - | - | 0 | 5.483 | 3.827 | 5.325 | 7.263 | 5.852 | -818 | -5.352 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medastan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 44 | 6.122 | 10.664 | 6.861 | 9.971 | 16.723 | 16.768 | 11.322 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.944 | 3.027 | 2.806 | 3.228 | 4.389 | 3.984 | 4.078 |
| Cash | - | - | 44 | 4.177 | 7.637 | 4.055 | 6.744 | 12.335 | 12.784 | 7.244 |
| Shareholders Funds | - | - | 44 | 5.526 | 9.247 | 5.375 | 8.476 | 14.354 | 13.493 | 8.065 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 595 | 1.418 | 1.486 | 1.496 | 2.369 | 3.275 | 3.257 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medastan Srl